Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Abrin and Ricin: New Anti-tumour Substances

Abstract

Abrin and ricin are highly toxic proteins isolated and crystallized from Abrus precatorius1 and Ricinus communis respectively2–4. The LD50s of abrin and ricin are 0.020 0.012 mg/kg body weight of mice respectively. Both have a molecular weight of 65,000, but a different chemical structure as judged by the analysis of N and C terminal amino-acid residues. For abrin these are leucine5, while the N-termini of ricin are alanine and isoleucine, and the C-termini are phenylalanine and serine2,6. The biological activities of the two proteins are alike; both cause similar toxic symptoms and have no effect on mitochondrial respiration7,8. The inhibitory effect of abrin and ricin on Ehrlich ascites tumour has been demonstrated by simultaneous injection of a sublethal dose with the tumour cells. Total inhibition of tumour growth in mice was demonstrated by measurements of body weight and total cell numbers in the peritoneal cavity. The therapeutic index of abrin was found to be 4. These inhibitory effects can be eliminated by heating the phytotoxin solution at 100° C for 30 min9,10, which indicates that the anti-tumour activity of phytotoxins is due to protein.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Lin, J. Y., Lei, L. L., and Tung, T. C., J. Formosan Med. Assoc. 68, 32 (1969).

    Google Scholar 

  2. Lin, J. Y., Tserng, K. Y., and Tung, T. C., J. Formosan Med. Assoc. (in the press).

  3. Kabat, E. E., Heidelberger, M., and Bezer, A. E., J. Biol. Chem., 168, 629 (1947).

    CAS  PubMed  Google Scholar 

  4. Ishiguro, M., Takahashi, T., Hayashi, K., and Funatsu, M., J. Biochem., 56, 50 (1962).

    Google Scholar 

  5. Lin, J. Y., Lan, C. Y., Lin, L. T., and Tung, T. C., J. Formosun Med. Assoc., 68, 325 (1969).

    CAS  Google Scholar 

  6. Funatsu, M., and Funatsu, G., Protein, Nucleic Acid and Enzyme, 13, 905 (1968).

    CAS  Google Scholar 

  7. Lin, J. Y., Chen, C. C., Lin, L. T., and Tung, T. C., J. Formosan Med. Assoc., 68, 322 (1969).

    CAS  Google Scholar 

  8. Walter, G. R., Ebner, K. E., Scroggs, R. A., Das Gupta, B. R., and Corcoran, J. B., J. Exp. Med., 121, 683 (1969).

    Google Scholar 

  9. Lin, J. Y., Chen, C. C., Lin, L. T., and Tung, T. C., J. Formosan Med. Assoc., 68, 522 (1969).

    CAS  Google Scholar 

  10. Lin, J. Y., Lin, L. T., Chen, C. C., Tserng, K. Y., and Tung, T. C., J. Formosan Med. Assoc., 69 (in the press).

  11. Eaton, M. D., Scala, A. R., and Jewell, M., Cancer Res., 19, 945 (1969).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

LIN, JY., TSERNG, KY., CHEN, CC. et al. Abrin and Ricin: New Anti-tumour Substances. Nature 227, 292–293 (1970). https://doi.org/10.1038/227292a0

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1038/227292a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing